参考文献/References:
[1]中国心血管病预防指南(2017)写作组,中华心血管病杂志编辑委员会.中国心血管病预防指南(2017)[J].中华心血管病杂志,2018,46(1):10-25. [2]黄峰,朱鹏立,肖华贞,等.福建沿海地区正常高值血压及高血压人群现况及其心血管危险因素的调查[J].中华心血管病杂志,2013,41(10):876-881. [3]韩雪玉,齐玥,赵冬,等.中国人群长期血压变化与心血管病发病风险关系的前瞻性队列研究[J].中华心血管病杂志,2018,46(9):695-700. [4]中国高血压防治指南修订委员会,高血压联盟(中国),中华医学会心血管病学分会,等.中国高血压防治指南(2018年修订版)[J].中国心血管杂志,2019,24(1):24-56. [5]Egan BM,Julins S.Prehypertension: risk stratification and management considerations [J].Current Hypertens Rep,2008,10(5):359-366. [6]中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-950. [7]Wang Z,Chen Z,Zhang L,et al.Status of Hypertension in China: Results from the China Hypertension Survey,2012-2015[J].Circulation,2018,137(22):2344-2356. [8]陈志华,张梅,李镒冲,等.我国成年人血压水平与心血管疾病行为危险因素及其聚集关系分析[J].中华流行病学杂志,2018,39(5):640-645. [9]Lu JP,Lu Y,Wang XC,et al.Prevalence, awareness, treatment, and control of hypertension in china: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project)[J].Lancet,2017,390(10112):2549-2558. [10]马琳.2017年ACC/AHA高血压指南新定义的血压分级水平及其变化与心血管疾病发病风险的前瞻性研究[D].华中科技大学,2019. [11]郭丽花,俞敏,钟节鸣,等.桐乡市社区高血压患者心血管病发病风险评估[J].预防医学,2019,31(2):124-127.
相似文献/References:
[1]颜 明,龚丽娜,王淑清.彩超在高血压患者肾动脉血流动力学检测中的应用分析[J].医学信息,2018,31(02):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
YAN Ming,GONG Li-na,WANG Shu-qing.Application of Color Doppler Ultrasound in the Measurement of Renal Artery Hemodynamics in Patients with Hypertension[J].Medical Information,2018,31(14):156.[doi:10.3969/j.issn.1006-1959.2018.02.060]
[2]夏能能,任 薇,杜建平,等.1953~2016年中医药治疗高血压领域研究热点分析[J].医学信息,2018,31(04):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
XIA Neng-neng,REN Wei,DU Jian-ping,et al.Analysis of Hot Spots in the Research of Traditional Chinese Medicine in Treating Hypertension from 1953 to 2016[J].Medical Information,2018,31(14):18.[doi:10.3969/j.issn.1006-1959.2018.04.007]
[3]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Medical Information,2018,31(14):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[4]乔 君,高 翔,王 瑜,等.缬沙坦对原发性高血压患者外周PBMC中IL-17表达的影响[J].医学信息,2018,31(07):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
QIAO Jun,GAO Xiang,WANG Yu,et al.The Effect of Valsartan on the Expression of IL-17 in Peripheral PBMC of Patients with Essential Hypertension[J].Medical Information,2018,31(14):65.[doi:10.3969/j.issn.1006-1959.2018.07.021]
[5]董巧玲.健康教育对原发性高血压患者治疗效果的影响[J].医学信息,2018,31(09):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
DONG Qiao-ling.Effect of Health Education on Treatment of Patients with Essential Hypertension[J].Medical Information,2018,31(14):180.[doi:10.3969/j.issn.1006-1959.2018.09.060]
[6]沈 正,王庆海.焦虑抑郁障碍与血压变异性研究[J].医学信息,2018,31(16):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
SHEN Zheng,WANG Qing-hai.Study on Anxiety and Depression Disorder and Blood Pressure Variability[J].Medical Information,2018,31(14):34.[doi:10.3969/j.issn.1006-1959.2018.16.010]
[7]左洪亮.苯磺酸左旋氨氯地平片治疗中老年患者
轻中度原发性高血压的疗效观察[J].医学信息,2018,31(16):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
ZUO Hong-liang.Efficacy of Levamlodipine Besylate Tablets in Treatment of Mild to Moderate Essential Hypertension in Middle-aged and Elderly Patients[J].Medical Information,2018,31(14):120.[doi:10.3969/j.issn.1006-1959.2018.16.037]
[8]袁 敏,周袁成.钙离子拮抗剂类降压药的临床应用与不良反应分析[J].医学信息,2018,31(17):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
YUAN Min,ZHOU Yuan-cheng.Clinical Application and Adverse Reaction Analysis of Calcium Antagonist Antihypertensive Drugs[J].Medical Information,2018,31(14):125.[doi:10.3969/j.issn.1006-1959.2018.17.038]
[9]陈学军,李 敏,张 丹,等.社区一体化分级管理模式对社区老年高血压患者的管理效果[J].医学信息,2018,31(18):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]
CHEN Xue-jun,LI Min,ZHANG Dan,et al.Management Effect of Community Integration Hierarchical Management Mode on Elderly Hypertensive Patients in Community[J].Medical Information,2018,31(14):169.[doi:10.3969/j.issn.1006-1959.2018.18.055]
[10]张莉莉.左旋氨氯地平和氨氯地平治疗轻中度高血压临床效果观察[J].医学信息,2018,31(21):149.[doi:10.3969/j.issn.1006-1959.2018.21.043]
ZHANG Li-li.Clinical Efficacy of Levamlodipine and Amlodipine in Treatment of Mild to Moderate Hypertension[J].Medical Information,2018,31(14):149.[doi:10.3969/j.issn.1006-1959.2018.21.043]